RSS Feed
TwitterSamuel Kunz, an accused Nazi who was awaiting trial for his alleged involvement in the killing of Jews at the Belzec concentration camp in Polans, passed away recently before his trial. Kunz was 89 when he died on November 18th. Kunz’s role in the atrocities allegedly involved transporting Jews from trains to the gas chambers, [...]
Archive for November, 2010
Cancer Drug In Short Supply?
Posted by Emma Russo on November 23rd, 2010
Doxorubicin, a generic cancer-treatment drug commonly used against breast cancers and lymphomas, is in short supply, and cancer patients are suffering as a result, according to Dr. Greg Marino. The drug, also called adriamycin, reduces the incidence of recurrence of the cancers. The FDA has said it’s seeing a “record number” of drug shortages this [...]
Japan Likely To Defy China’s Request
Posted by Nathan Jackson on November 23rd, 2010
Despite China’s official request that Japan’s Norwegian ambassador not attend the awarding of the Nobel Peace Prize in December, Japan’s Foreign Minister indicated today that the ambassador plans to attend. Seiji Maehara, the Japanese Foreign Minister, said, “‘Japan believes it is a very important prize and the Japanese ambassador (to Norway) took part in past [...]
Posted in Featured News, World 
Tags: China, Japan, Liu Xiaobo, Nobel Peace Prize, Seiji Maehara 
No Comments »SAT Question Of The Day: SAT Prep Columnist Explains (11/22/2010)
Posted by Mike Barrett on November 22nd, 2010
The SAT Question of the Day for today, like the last one that I wrote about, has an explanation that is fundamentally flawed. (Here’s the permalink to today’s question from the College Board’s web site.) Trying to learn how to approach the SAT by listening to College Board explanations like this will actually make preparing [...]
Posted in Featured News Tags: education, Mike Barrett, SAT prep, SAT Question of the Day No Comments »FDA Says No To Darvon, Darvocet
Posted by Emma Russo on November 20th, 2010
Darvon and Darvocet will no longer be available on the US market soon. Today, the FDA announced that it is pulling the two painkillers because new studies indicate they may damage patients’ hearts when taken at the recommended doses, perhaps even fatally. In the study that led to the FDA’s recent decision, electrocardiograms of patients [...]
